Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data (Unaudited)

v3.20.1
Quarterly Financial Data (Unaudited)
12 Months Ended
Mar. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (Unaudited)

Note 18 - Quarterly Financial Data (Unaudited):

A capsule summary of the Company's unaudited quarterly results for fiscal 2020 and fiscal 2019 is presented below:

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

Year ended March 31, 2020

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

Net sales

 

$

20,593

 

 

$

21,643

 

 

$

25,286

 

 

$

23,082

 

 

$

90,604

 

Gross profit

 

 

4,714

 

 

 

4,948

 

 

 

4,044

 

 

 

4,442

 

 

 

18,148

 

Net income

 

 

82

 

 

 

1,205

 

 

 

9

 

 

 

576

 

 

 

1,872

 

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.01

 

 

$

.12

 

 

$

 

 

$

.06

 

 

$

0.19

 

Diluted

 

$

.01

 

 

$

.12

 

 

$

 

 

$

.06

 

 

$

0.19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$18.96-22.84

 

 

$17.70-23.25

 

 

$19.03-23.77

 

 

$11.07-21.90

 

 

$11.07-23.77

 

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

Year ended March 31, 2019

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

Net sales

 

$

29,551

 

 

$

21,441

 

 

$

17,198

 

 

$

23,641

 

 

$

91,831

 

Gross profit

 

 

7,142

 

 

 

6,227

 

 

 

3,742

 

 

 

4,798

 

 

 

21,909

 

Net (loss) income

 

 

2,323

 

 

 

1,827

 

 

 

95

 

 

 

(4,553

)

(1)

 

(308

)

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.24

 

 

$

.19

 

 

$

.01

 

 

$

(0.46

)

 

$

(0.03

)

Diluted

 

$

.24

 

 

$

.19

 

 

$

.01

 

 

$

(0.46

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$20.75-27.51

 

 

$22.55-28.98

 

 

$19.48-28.73

 

 

$19.00-24.90

 

 

$19.00-28.98

 

 

(1)  In the fourth quarter of fiscal 2019, the Company recorded goodwill and other impairment losses of $6,449 related to the commercial nuclear utility business that was held for sale at March 31, 2019.  As a result, net income in the fourth quarter of fiscal 2019 includes the impairment loss net of an income tax benefit of $1,129.